A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD
Trial details
- Registry ID
- NCT06979544
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Brexanolone
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDNCT06979544 | LPCN | Phase 3 | Completed | 2026-01-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |